Accord Healthcare US Revenue
Pharmaceutical Manufacturing • 
Triangle, North Carolina, United States • 21-50 Employees
Accord Healthcare US revenue & valuation
| Annual revenue | $2,737,760 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $8,800,000 |
| Total funding | No funding |
Key Contacts at Accord Healthcare US
Nelesh Ambre
Sr. Director - National Accounts.
Arlone Macatangay
Executive Director, Supply Chain Operations
Stephanie Papadelis
Director, National Accounts
Sushrath Kaul
Senior Director - Business Development Us
Fiona Ouyang
Director Of Fp&A And Gtn
Company overview
| Headquarters | 1009 Slater Road, Suite 210, Durham, NC 27703, US |
| Phone number | +18669417875 |
| Websites | |
| NAICS | 3254 |
| Employees | 21-50 |
| Socials |
Accord Healthcare US Email Formats
Accord Healthcare US uses 2 email formats. The most common is {first name}_{last name} (e.g., john_doe@accord-healthcare.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}_{last name} | john_doe@accord-healthcare.com | 66.7% |
{first initial}_{last name} | j_doe@accord-healthcare.com | 33.3% |
About Accord Healthcare US
Accord Healthcare is a large-scale provider of generic pharmaceuticals in the United States. Our U.S. headquarters is in Durham, North Carolina, near the Research Triangle Park (RTP). Situated in a 7,000-acre pine forest, RTP is one of the largest research parks in the world. Close to three major research universities, the area provides an unparalleled scientific, regulatory, quality, and commercial talent pool. Accord is the commercial arm of Intas Pharmaceuticals, a pioneering biopharmaceutical company operating in India since 1976. Selling in over 75 countries, Accord has a vast global presence. The Accord and Intas networks provide full integration in the functional areas vital to delivering quality excellence and service efficiencies: API and finished dosage form manufacturing, R & D, clinical program management, and the economies of scale inherent in worldwide distribution. Accord is routinely cited in IQVIA presentations to industry as one of the fastest growing pharmaceutical companies in the U.S. Quarter-over-quarter, we consistently accomplish double-digit growth across all the metrics: in dollar sales, scripts filled, and number of units sold. We have accomplished this while undergoing multiple plant expansions across all of our manufacturing sites. Our solid record of maintaining high quality standards while implementing strategic commercial expansion has set us apart in the industry. Accord’s product offerings and pipeline demonstrate our commitment to meeting the needs of healthcare professionals and patients alike. We currently have approval for more than 115 ANDAs and are selling over 290 dosing presentations. We have 52 ANDAs pending at the FDA, and over 115 products in active development. Our pipeline spans a full range of dosage forms: orals, topicals, transdermal patches, liquid, lyophilized and complex injectables.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Accord Healthcare US has 19 employees across 4 departments.
Departments
Number of employees
Funding Data
Accord Healthcare US has never raised funding before.
Accord Healthcare US Tech Stack
Discover the technologies and tools that power Accord Healthcare US's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
Maps
JavaScript libraries
Web servers
Font scripts
JavaScript libraries
Programming languages
Security
Blogs
Analytics
UI frameworks
South Africa
Canada
United Kingdom
BelgiumFrequently asked questions
4.8
40,000 users
